Head and Neck Squamous Cell Carcinom
1 clinical trials · Condition
◉ Watch Head and Neck Squamous Cell Carcinom
| Record | Firm | Date |
|---|---|---|
| The Safety and Efficacy of Multiple-dose of JS004 in Subject With HNC (NCT04929080) | Shanghai Junshi Bioscience Co., Ltd. | 2021-05-11 |
Track Head and Neck Squamous Cell Carcinom automatically
Every clearance here is in the API, with alerts when new ones post.